KMTS — Kestra Medical Technologies, Ltd. stock price, charts and financials

QT71Kestra Medical Technologies, Ltd.

Kestra Medical Technologies, Ltd. (NASDAQ: KMTS) is a Healthcare company in the Medical - Instruments & Supplies industry. QuoTrend tracks its price, financials, earnings, analyst ratings and insider trades.

Latest market price
28.35
+1.95+7.39%
OverviewShort InterestFilings
KMTSQT71Kestra Medical Technologies, Ltd.·NASDAQ
28.35+7.39%
TA
Loading chart...
Signal & projected range
Insider selling clusterHistorical pattern — not a prediction
Recent priceDays this stock last showed the setupRange of past outcomes (±1σ)
Horizon
0%Past 3 monthsToday
Unlock the projected rangeSee where this setup landed historically — with Premium.

Over the next 20 trading days, similar setups historically landed in a measured range of outcomes. Premium shows the median return, the typical range, and how often they were positive. This is the historical range of outcomes — not a prediction of this stock’s price.

Ranges describe how this exact setup resolved in the past — derived from thousands ofhistorical occurrences across QuoTrend’s coverage since 2006, survivorship-corrected to include companies that later delisted. The band is the typical spread (±1σ) of those outcomes, not a forecast; the central value is their average move. Fewer matching cases over longer horizons widen the band and lower its reliability. Backtested results are hypothetical, based on historical data, and do not represent actual trading. Past performance does not guarantee or predict future results. QuoTrend is an educational research tool, not investment advice. Markets involve risk, including loss of principal.

Screen all →
AZTA+4.03%$33.33BLFS-0.06%$34.64LMAT-0.32%$81.19STAA+3.76%$25.12ATRC+0.60%$41.64XRAY-3.80%$11.66QDEL+11.93%$13.75PLSE-2.12%$41.51
Snapshot
Index-P/E-EPS (ttm)-2.42Insider Own2.11%Shs Outstand58.60MPerf Week15.64%
Market Cap1.55BForward P/E-EPS next Y-2.05Insider Trans-21.14%Shs Float33.06MPerf Month-1.09%
Enterprise Value1.45BPEG-EPS next Q-0.61Inst Own-Short Float9.37%Perf Quarter22.68%
Income-132.12MP/S16.26EPS this Y4.84%Inst Trans-Short Ratio8.95Perf Half Y5.10%
Sales95.13MP/B5.94EPS next Y10.98%ROA-36.72%Short Interest3.10MPerf YTD-0.45%
Book/sh-P/C-EPS next 5Y-ROE-58.76%52W High32.22 -12.00%Perf Year82.57%
Cash/sh-P/FCF-EPS past 3/5Y-ROIC-43.73%52W Low15.14 87.23%Perf 3Y-
Dividend Est.-EV/EBITDA-Sales past 3/5Y128.15% -Gross Margin51.37%Volatility5.75% 6.80%Perf 5Y-
Dividend TTM-EV/Sales15.26EPS Y/Y TTM52.83%Oper. Margin-141.64%ATR (14)1.60Perf 10Y-
Dividend Ex-Date-Quick Ratio4.41Sales Y/Y TTM60.00%Profit Margin-138.36%RSI (14)61.03Recom2.25
Dividend Gr. 3/5Y-Current Ratio4.41EPS Q/Q46.40%SMA2011.62%Beta1.74Target Price31.00
Payout-0.25%Debt/Eq0.02Sales Q/Q70.59%SMA5015.41%Rel Volume0.75Prev Close26.40
Employees443LT Debt/Eq0.18EarningsSep 10SMA20012.10%Avg Volume368.67KPrice28.35
IPO DateMar 06, 2025Option/ShortYes / YesEPS/Sales Surpr.-13.56% 8.15%Net Debt/EBITDA0.73Volume275,724Change7.39%
Analyst Ratings
DateActionAnalystRatingTarget
Jul-15-26ReiteratedWolfe Research$30
Jul-15-26ReiteratedBTIGBuy$32
Jan-16-26ReiteratedGoldman SachsNeutral$27 → $24
Jan-09-26ReiteratedGoldman SachsNeutral$25 → $27
Dec-12-25ReiteratedStifel Nicolaus$28 → $30
Dec-12-25ReiteratedPiper SandlerOverweight$30
Dec-12-25ReiteratedWells FargoOverweight$28
Latest News
Aug-05-26
Aug-05-2609:06AM
Strength Seen in Kestra Medical Technologies, Ltd. (KMTS): Can Its 8.1% Jump Turn into More Strength?zacks.com
Jul-21-26
Jul-21-2608:23AM
Oppenheimer Initiates Coverage On Kestra Medical Techs with Perform RatingBenzinga
Jul-14-26
Jul-14-2608:40PM
Kestra Medical Technologies (NASDAQ:KMTS) Revenue Beat and EPS Miss Create Mixed Setup After Recent RallyChartMill
06:59PM
Kestra Medical Technologies, Ltd. (KMTS) Q4 2026 Earnings Call Transcriptseekingalpha.com
06:11PM
Kestra Medical Technologies, Ltd. (KMTS) Reports Q4 Loss, Tops Revenue Estimateszacks.com
06:03PM
Kestra Medical Technologies Q4 Earnings Call Highlightsmarketbeat.com
04:05PM
Kestra Medical Technologies Secures Up to $200 Million of Non-Dilutive Financingglobenewswire.com
04:01PM
Kestra Medical Technologies Reports Fourth Quarter and Fiscal Year 2026 Financial Resultsglobenewswire.com
Jun-30-26
Jun-30-2604:05PM
Kestra Medical Technologies to Report Fourth Quarter Fiscal 2026 Financial Results on July 14globenewswire.com
Company

Kestra Medical Technologies, Ltd. operates at the intersection of wearable medical technology and digital healthcare. Its core mission is to revolutionize patient outcomes in cardiovascular disease through intelligent, intuitive, and connected monitoring and therapeutic intervention solutions. The company's flagship offering is the Cardiac Recovery System (CRS) platform, which it develops and commercializes. This unified solution seamlessly integrates cardiac monitoring, therapeutic treatment, digital health capabilities, and patient support services. A central component of the CRS is the ASSURE WCD, a wearable cardioverter defibrillator specifically engineered to protect individuals at elevated risk of sudden cardiac arrest (SCA). Beyond its hardware, the CRS platform also encompasses a suite of integrated digital solutions and services. These are designed to foster enhanced engagement and oversight between patients and healthcare providers, ultimately striving for improved patient well-being. Founded in 2014, the company is headquartered in Kirkland, Washington.

Ownership

Per-holder 13F data hasn't been ingested for this ticker yet.

Financial Statements
DataTimeframe
Line Item (USD, M)
TTM
—
FY 2026
4/30/2026
FY 2025
4/30/2025
FY 2024
4/30/2024
FY 2023
4/30/2023
Total Revenue969560——
Cost of Goods Sold Incl. D&A474636——
Gross Profit494924——
Selling, General and Administrative Excl. Other164164115——
Research and Development201916——
Other Operating Expense010——
Operating Income-135-135-106——
Interest Expense888——
Unusual Expense
—————
Non-Operating Income (Expense)12110——
Net Income Before Taxes-132-131-114——
Income Taxes
000——
Consolidated Net Income-132-132-114——
Net Income From Continuing Operations-132-132-114——
Net Income-132-132-114——
EPS (Recurring)-2.42-2.43-5.13——
EPS (Basic, Before Extraordinaries)-2.42-2.43-5.13——
EPS (Diluted)-2.42-2.43-5.13——
EBITDA-130-150-98——
Other After Tax Adjustments
—————
Stock Option Compensation Expense
—————
Price To Earnings Ratio
—————
Price To Sales Ratio17.1312.6520.05——
Gross Margin51.0451.5840.00——
Operating Margin-140.63-142.11-176.67——
Net Margin-137.50-138.95-190.00——
Shares Outstanding585850——
Market Capitalization1,6441,2021,203——
Operating Lease Expense
—————
Unlock full historical data
See years of past statements with Premium.
Insider Trading Volume
$30.04$25.64$21.23$16.83$12.43● Close Price0.00M0.67M1.34M2.00M2.67MUSD Trades VolumeAugSepOctNovDec2026FebMarAprMayJunJulAug
Insider Trading
InsiderRelationshipDateTransactionCost#SharesValue ($)#Shares TotalSEC Form 4
Mahboob VaseemChief Financial OfficerAug 04 '26Sale24.686,995172,63586,896Aug 06
Webster Brian DanielSee RemarksAug 04 '26Sale24.5251,9001,272,588475,215Aug 06
Umberger Traci SSee RemarksAug 04 '26Sale24.043,58086,073195,825Aug 06
Ford Alfred J JrChief Commercial OfficerAug 04 '26Sale24.096,275151,14199,564Aug 06
Umberger Traci SSee RemarksAug 03 '26Sale23.867,590181,062199,405Aug 03
Webster Brian DanielSee RemarksAug 03 '26Sale23.9213,017311,424527,115Aug 03
Mahboob VaseemChief Financial OfficerAug 03 '26Sale23.805,391128,31293,891Aug 03
Moran Timothy P.Chief Business OfficerAug 03 '26Sale23.762,38056,55166,345Aug 03
Ford Alfred J JrChief Commercial OfficerAug 03 '26Sale23.9013,015311,118105,839Aug 03
Moran Timothy P.Chief Business OfficerJul 31 '26Sale22.618,759198,00168,725Aug 03
Webster Brian DanielSee RemarksJul 31 '26Sale22.608,948202,260540,132Aug 03
Umberger Traci SSee RemarksJul 31 '26Sale22.608,752197,837206,995Aug 03
Ford Alfred J JrChief Commercial OfficerJul 31 '26Sale22.618,681196,284118,854Aug 03
Mahboob VaseemChief Financial OfficerJul 31 '26Sale22.618,817199,34499,282Aug 03
Umberger Traci SSee RemarksJul 30 '26Sale22.745,887133,892215,747Aug 03
open in yahoo·open in reuters·open in marketwatch·open in google·open in EDGAR
QuoTrend signals describe historical patterns and statistics — educational information, not investment advice or a recommendation to buy or sell. Past performance doesn’t guarantee future results. Every figure traces to QuoTrend data. Historical patterns — not a prediction or advice.